Criminal Justice (Drug Policy)

in committee · Washington · House Feb 5, 2026

HB 2731: Prohibiting local jurisdictions from banning cannabis production, processing, and sales.

HB 2731 prohibits local governments in Washington from banning cannabis businesses by banning ordinances, regulations, or land use plans that would prevent licensed producers, processors, or retailers from operating in their jurisdictions. The bill also expands the state's social equity program for cannabis licenses, requiring that at least 51% of ownership in new licenses meets specific criteria (e.g., living in a historically impacted area, having a cannabis-related arrest, or meeting income thresholds). It sets aside additional licenses for social equity applicants and mandates a scoring system to prioritize them. This law directly affects local governments (by removing their ban authority), cannabis businesses (by expanding operational areas), and social equity applicants (by creating priority access to new licenses).

Topics ✓ Criminal JusticeSupports Criminal JusticeExpands social equity program requiring 51% license ownership from historically impacted communities affected by cannabis arrests, directly addressing criminal justice disparities from past enforcement policies.92% confidence

Sub-Topics Drug Policy

Track

in committee · Washington · Senate Jan 26, 2026

SB 6307: Concerning correctional facility liability for inmate injuries resulting from voluntary controlled substance use, when lawful intake and medical care requirements are met.

This bill limits state and local government liability for injuries to inmates caused by their voluntary use of controlled substances under specific conditions. It protects correctional facilities (jails, prisons, or similar facilities owned/operated by the state or local government) if they lawfully screened inmates for drugs upon admission, removed any found substances, and the injury resulted from the inmate’s own drug use. Exceptions apply if facility staff provided the drugs or failed to provide medical care when they knew an inmate needed it. The law applies to cases occurring after its effective date and does not affect liability for injuries caused by facility-provided substances.

Topics ✗ Criminal JusticeOpposes Criminal JusticeLimits correctional facility liability for inmate drug injuries, reducing accountability and oversight in criminal justice facilities.95% confidence

Sub-Topics Corrections Drug Policy

Track

in committee · Washington · Senate Feb 26, 2026

SB 6204: Legalizing the home cultivation of cannabis by persons who are 21 years of age and older.

SB 6204 legalizes home cannabis cultivation for Washington residents aged 21 and older, allowing up to six plants per household (with a maximum of 15 plants total for a single residence). It sets specific limits on cannabis products, including 0.5 ounces of useable cannabis, 36 ounces of liquid-infused products, or 100 milligrams of THC per 24-hour period for noncommercial sharing. The bill prohibits visible cultivation from public view or neighboring properties and maintains criminal penalties for exceeding these limits or for possession by those under 21. It explicitly excludes medical cannabis patients (covered under separate law) and clarifies that commercial cannabis regulations remain unaffected.

Topics ✓ Criminal JusticeSupports Criminal JusticeLegalizes home cannabis cultivation, reducing criminalization of non-commercial use and aligning with criminal justice reform goals by decreasing arrests for low-level offenses.85% confidence

Sub-Topics Drug Policy

Track

in committee · Washington · House Jan 22, 2026

HB 2614: Legalizing the home cultivation of cannabis by persons who are 21 years of age and older.

HB 2614 legalizes home cultivation of cannabis for Washington residents aged 21 or older, permitting up to six plants per person on their premises with a maximum of 15 plants total per housing unit. It sets specific possession limits (e.g., no more than half an ounce of useable cannabis) and requires cultivation to remain non-visible from public view to avoid penalties. Violations like exceeding plant limits or visible cultivation would result in civil penalties, not criminal charges. The bill does not affect medical cannabis programs or commercial cannabis businesses.

Topics ✓ Criminal JusticeSupports Criminal JusticeShifts penalties for cannabis cultivation from criminal to civil, reducing criminal justice involvement and aligning with reform goals of decriminalization.95% confidence

Sub-Topics Drug Policy

Track

in committee · Washington · House Jan 12, 2026

HB 2393: Concerning correctional facility liability for inmate injuries resulting from voluntary controlled substance use, when lawful intake and medical care requirements are met.

This bill limits state and local government liability for injuries to inmates caused by their voluntary use of controlled substances under specific conditions. It applies when inmates were lawfully searched upon admission (with any substances seized), and the facility met medical care requirements. However, liability still applies if the facility or government provided the substance or failed to provide medical care when they knew an inmate needed it. The law affects correctional facilities (jails, prisons) and the government entities that operate them, changing how liability is determined in such cases.

Topics ✗ Criminal JusticeOpposes Criminal JusticeLimits correctional facility liability for inmate injuries from voluntary substance use, weakening accountability and oversight in criminal justice facilities.95% confidence

Sub-Topics Corrections Drug Policy

Track

in committee · Washington · Senate Jan 14, 2026

SB 6145: Concerning the possession of contraband at any correctional facility or institution by an employee.

SB 6145 requires immediate suspension and termination of state and contractor employees at correctional facilities who possess contraband (such as weapons, drugs, or security-threatening items) on facility premises. Employees found guilty of contraband possession through evidence-based review or related criminal convictions must be terminated, and contractors must remove such employees from facility-access roles. Contractors must also demonstrate improved hiring, training, and monitoring practices to renew contracts, with the department requiring proof of progress before approval. The bill allows public disclosure of terminated employees or contracts, protecting officials from liability for releasing relevant information.

Topics ✓ Criminal JusticeSupports Criminal JusticeStrengthens correctional facility security by mandating termination for employee contraband possession, enhancing institutional safety and accountability within the criminal justice system.85% confidence

Sub-Topics Corrections Drug Policy

Track

in committee · Washington · House Jan 12, 2026

HB 1087: Expanding the crime of endangerment with a controlled substance to include fentanyl and other high-potency synthetic opioids.

HB 1087 expands Washington's "endangerment with a controlled substance" law to include fentanyl and other high-potency synthetic opioids, in addition to methamphetamine. It directly affects individuals who knowingly expose dependent children or adults to these substances. The bill amends the law to specifically list fentanyl (and its salts/isomers) and other defined high-potency synthetic opioids as covered substances, making such exposure a class B felony. This change explicitly excludes cases where substances are administered under a valid prescription, as outlined in chapter 69.50 RCW.

Topics ✗ Criminal JusticeOpposes Criminal JusticeExpands criminalization of substance exposure to fentanyl, increasing felony penalties without reform elements; aligns with 'expands criminalization' indicator.95% confidence

Sub-Topics Drug Policy

Track

in committee · Washington · House Jan 12, 2026

HB 1229: Resentencing of individuals sentenced as a persistent offender.

HB 1229 allows individuals sentenced as persistent offenders or receiving exceptional sentences (to avoid persistent offender status) due to a second-degree robbery conviction to seek resentencing. It requires public defense offices to review cases where second-degree robbery was used to establish persistent offender status or as part of a plea agreement, and to file motions for resentencing if eligible. The bill mandates courts to resentence these individuals as if second-degree robbery was not the "most serious offense" at sentencing, effectively removing it from consideration in sentencing calculations. This policy change applies to both current sentences and future cases after July 2021, ensuring second-degree robbery no longer qualifies as a "most serious offense" for persistent offender sentencing.

Topics ✓ Criminal JusticeSupports Criminal JusticeBill enables resentencing for persistent offenders convicted of second-degree robbery, reducing harsh mandatory sentences and advancing criminal justice reform to lower recidivism.95% confidence

Sub-Topics Drug Policy Sentencing Victims' Rights

Track

in committee · Washington · House Jan 12, 2026

HB 1331: Increasing public safety by elevating the penalty for unlawful delivery of a controlled substance resulting in death.

HB 1331 changes the legal classification for cases where someone unlawfully delivers a controlled substance (like drugs) that causes the death of the person who used it. It reclassifies this as "manslaughter in the first degree" (a class A felony) under Washington law, instead of the previous penalty structure. This specifically affects individuals who deliver drugs that directly result in a user's death, such as in overdose cases. The bill repeals the existing "controlled substances homicide" penalty section (RCW 69.50.415) to implement this new classification. The change aims to strengthen penalties for drug dealers whose actions cause fatal outcomes.

Topics ✗ Criminal JusticeOpposes Criminal JusticeBill reclassifies drug delivery causing death as first-degree manslaughter (class A felony), increasing penalties and expanding criminalization, opposing reform indicators like reduced sentences.95% confidence

Sub-Topics Drug Policy Violent Crime

Track

in committee · Washington · House Jan 12, 2026

HB 2072: Sustaining and expanding behavioral health services by levying an opioid impact fee on opioid manufacturers.

HB 2072 imposes a fee of $0.01 per morphine milligram equivalent on opioid manufacturers for prescription opioids dispensed in Washington. The fee funds a new "prescription opioid impact account," with 50% dedicated to behavioral health programs for children, youth, and young adults. Funds also reimburse the state for modifying the prescription monitoring program and cover administrative costs (capped at 12% annually). Manufacturers must report quarterly opioid dispensing data to the Department of Health and pay the fee within 45 days, with penalties for late payment.

Topics ✓ Budget & TaxesSupports Budget & TaxesImposes manufacturer fee to fund behavioral health programs via dedicated account, directly advancing budget allocation for public services.95% confidence ✓ Criminal JusticeSupports Criminal JusticeFunds behavioral health programs for youth, addressing root causes of criminal justice involvement per reform indicators like reducing recidivism.75% confidence ✓ HealthcareSupports HealthcareBill funds behavioral health programs for youth via opioid manufacturer fee, directly expanding mental health services funding as per bill's explicit purpose.95% confidence

Sub-Topics Drug Policy Mental Health Substance Abuse

Track